Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Octapharma AG is one of the largest human protein product manufacturers in the world, developing and producing high-quality human proteins from human plasma and human cell lines. Headquartered in Lachen, Switzerland, Octapharma was founded in 1983 by Wolfgang Marguerre. The company is dedicated to patient care and medical innovation, focusing on three therapeutic areas: Haematology, Immunotherapy, and Critical Care. Octapharma employs thousands worldwide and distributes its life-saving products to patients in 118 countries. They own state-of-the-art production facilities and a network of plasma donation centers (Octapharma Plasma Inc. in the US and Germany).
The Lachen headquarters serves as the central hub for Octapharma's global operations, strategic planning, corporate governance, research and development oversight, and international commercial activities.
The headquarters is a modern facility, likely designed to foster collaboration and reflect Swiss precision and quality. While specific architectural awards aren't widely publicized, its location and design are intended to support a high-performance, innovative environment.
The work culture at Octapharma HQ is characterized by a strong emphasis on scientific excellence, quality, patient focus, and entrepreneurial spirit. It fosters an international, collaborative environment driven by its mission to provide life-saving therapies.
Its Swiss location provides political and economic stability, access to a highly skilled workforce, and a strong reputation in the pharmaceutical industry. The headquarters is pivotal for coordinating global R&D, manufacturing, and distribution efforts.
Octapharma AG operates globally, with its products available in 118 countries. This extensive reach is supported by a network of five state-of-the-art production facilities in Austria, France, Germany, Mexico, and Sweden, numerous R&D sites, over 190 plasma donation centers (primarily in the US and Germany through Octapharma Plasma, Inc.), and commercial offices worldwide. Key global functions include research and development, manufacturing, quality assurance, regulatory affairs, supply chain management, and sales & marketing, all coordinated to ensure patient access to their human protein therapies.
Seidenstrasse 2
Lachen
SZ (Schwyz)
Switzerland
Address: Oberlaaer Strasse 235, 1100 Wien, Austria
Serves as a critical hub for European manufacturing and research, supplying products globally and supporting innovation across therapeutic areas.
Address: Lars Forssells gata 23, 112 15 Stockholm, Sweden
Key Nordic research and production center, contributing to Octapharma's innovative product pipeline, especially in recombinant therapies.
Address: Elisabeth-Selbert-Strasse 11, 31832 Springe, Germany
Strengthens Octapharma's manufacturing capacity in Europe, ensuring supply of critical plasma-derived medicines.
Address: 72 Rue du Maréchal Foch, 67380 Lingolsheim, France
Contributes to Octapharma's European production network and serves the French and international markets.
Address: 117 Park Avenue, Hoboken, NJ 07030, USA
Manages and expands Octapharma's presence in the critical U.S. market for its hematology, immunotherapy, and critical care products.
Address: 1210 Northpointe Centre Drive, Charlotte, NC 28216, USA
Crucial for securing a high-quality plasma supply, the raw material for Octapharma's life-saving therapies.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Octapharma AG' leadership includes:
Octapharma AG has been backed by several prominent investors over the years, including:
As a privately-held company, Octapharma AG does not publicize all executive movements as frequently as publicly traded companies. Major board-level changes are typically announced via official press releases. No major, widely publicized changes to the core executive board (as listed) have been noted in the last 12-18 months, indicating stability in top leadership. Any changes would likely be internal promotions or strategic appointments announced on their corporate website.
Discover the tools Octapharma AG uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Octapharma AG commonly uses the [first].[last]@octapharma.com email format for its employees. Variations might exist, but this is a widely observed pattern.
[first].[last]@octapharma.com
Format
john.doe@octapharma.com
Example
85%
Success rate
Octapharma AG Website • May 7, 2024
Octapharma announced new data from the PEDIQUIG study, confirming the good efficacy, safety and tolerability of its 16.5% subcutaneous immunoglobulin (SCIG), cutaquig®, in children with primary immunodeficiency (PID). The findings were presented at the Clinical Immunology Society (CIS) 2024 Annual Meeting....more
Octapharma AG Website • April 16, 2024
Octapharma Group announced strong financial performance for 2023, with sales of €3.268 billion, a 14.1% increase over 2022. The company also reported significant investments in R&D, plasma collection capacity, and production capabilities to meet the growing global demand for its plasma-derived therapies....more
Octapharma AG Website • February 29, 2024
Octapharma announced it would present new data from its haematology portfolio at the European Association for Haemophilia and Allied Disorders (EAHAD) Congress 2024, highlighting its ongoing commitment to advancing care for patients with bleeding disorders....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Octapharma AG, are just a search away.